Oxford scientists race to find best COVID-19 antiviral drugs

NCT ID NCT05041907

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

Summary

This trial is testing multiple antiviral drugs to see which ones work best at clearing the COVID-19 virus from people with early symptoms. The study involves 3,800 previously healthy adults aged 18-60 who have just tested positive. Researchers will compare how quickly different drugs reduce virus levels compared to no treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bangplee Hospital
TERMINATED

Mueang Samut Prakan, 10540, Thailand
Faculty of Tropical Medicine, Mahidol University
RECRUITING

Bangkok, 10400, Thailand

Contact Email: •••••@•••••
Laos-Oxford-Mahosot Wellcome Trust Research Unit
RECRUITING

Vientiane, 01000, Laos

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sukraraj Tropical & Infectious Disease Hospital
RECRUITING

Kathmandu, Nepal

Contact Email: •••••@•••••
The Aga Khan University Hospital
TERMINATED

Karachi, Pakistan
Universidade Federal de Minas Gerais
RECRUITING

Minas Gerais, Brazil

Contact Email: •••••@•••••
Vajira hospital
TERMINATED

Bangkok, 10300, Thailand

Conditions

Explore the condition pages connected to this study.

COVID-19